Finance

Beta
Daftar
Sektor ekuitas
Simbol
Simbol
Harga
Perubahan
Persentase Perubahan
Tren
Penutupan Sebelumnya
Buka
Tinggi
Rendah
Volume
Kapitalisasi Pasar
SIXB
Materials
SIXB
Materials
SIXB
-0,23%
1.101,51
-2,59
-0,23%
โ€”1.104,101.103,921.108,751.097,16โ€”โ€”
SIXC
Communications
SIXC
Communications
SIXC
+0,21%
605,41
+1,25
+0,21%
โ€”604,16604,16610,19604,12โ€”โ€”
SIXE
Energy
SIXE
Energy
SIXE
-0,13%
1.196,27
-1,54
-0,13%
โ€”1.197,811.200,581.213,071.192,02โ€”โ€”
SIXI
Industrials
SIXI
Industrials
SIXI
-0,01%
1.740,22
-0,17
-0,01%
โ€”1.740,411.739,551.750,271.730,60โ€”โ€”
SIXM
Financials
SIXM
Financials
SIXM
+0,69%
638,79
+4,35
+0,69%
โ€”634,44633,13639,87633,01โ€”โ€”
SIXR
Staples
SIXR
Staples
SIXR
-1,05%
832,07
-8,83
-1,05%
โ€”840,90839,53841,73831,10โ€”โ€”
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,82%
213,37
-1,76
-0,82%
โ€”215,13215,13215,85213,24โ€”โ€”
SIXT
Technology
SIXT
Technology
SIXT
+0,15%
3.233,69
+4,98
+0,15%
โ€”3.228,713.225,623.235,433.198,95โ€”โ€”
SIXU
Utilities
SIXU
Utilities
SIXU
+0,06%
936,40
+0,53
+0,06%
โ€”935,87938,37942,00935,79โ€”โ€”
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.449,58
-7,52
-0,52%
โ€”1.457,121.452,741.466,881.449,55โ€”โ€”
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,69%
2.383,20
-16,64
-0,69%
โ€”2.399,842.389,712.394,612.371,22โ€”โ€”
LGDN:FRA
Ligand Pharmaceuticals Inc
โ‚ฌ200,00
+5,26%
(+10,00) 1 HR
27 Apr, 22.00.00 GMT+2  ·   EUR
Semua simbol
SimbolHargaPerubahanPersentase Perubahan
Membuat insight teratas untuk LGDN...
Buka
โ‚ฌ194,00
Tinggi
โ‚ฌ200,00
Rendah
โ‚ฌ194,00
Kapitalisasi pasar
4,85ย M
Volume rata-rata
3,00
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
โ‚ฌ200,00
Harga rendah dalam 52 minggu terakhir
โ‚ฌ87,00
Jumlah karyawan
47
Artikel berita
Dari berbagai sumber di seluruh web
Profil
Ligand Pharmaceuticals is an American biopharmaceutical company that focuses on acquiring and developing royalty-generating assets. As of 2024, the company's portfolio included royalty rights to approximately 90 pharmaceutical products across a range of therapeutic areas. Notable products from which Ligand receives royalties include the multiple myeloma treatments Kyprolis and Evomela, the kidney disease therapy Filspari, and the pneumococcal vaccine Vaxneuvance. The company also owns the drug development technology platform Captisol. The company was founded in 1987 as Progenx by venture capitalist Brook Byers; it was renamed Ligand Pharmaceuticals in 1989 and went public in 1992. Following an accounting scandal that led to its delisting from the Nasdaq stock exchange in 2005, the company underwent a major restructuring. Under former CEO John Higgins, who took over in 2007, Ligand shifted its focus from drug development to its current business model of generating revenue from royalties and licensing payments. Ligand has grown its portfolio primarily through acquisitions, including Pharmacopeia in 2008, CyDex Pharmaceuticals in 2011, and Pfenex in 2020. Wikipedia
Tentang Ligand Pharmaceuticals Inc
CEO-
Karyawan47
DidirikanSep 1987
Kantor PusatJupiter, Florida, Amerika Serikat
Sektor-
Situsligand.com
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Laporan laba rugi
Pendapatan
Penghasilan bersih
Semua nilai dalam USD
Mar 2025
Jun 2025
Sep 2025
Des 2025
Pendapatan
45,33ย jt
47,63ย jt
115,46ย jt
59,67ย jt
Harga pokok penjualan
54,93ย jt
9,47ย jt
24,82ย jt
6,50ย jt
Biaya pendapatan
54,93ย jt
9,47ย jt
24,82ย jt
6,50ย jt
Biaya riset dan pengembangan
-
-
-
-
Total biaya riset dan pengembangan
-
-
-
-
Biaya penjualan, umum, dan administrasi
18,80ย jt
20,18ย jt
28,45ย jt
25,03ย jt
Biaya operasional
27,06ย jt
28,43ย jt
36,54ย jt
33,12ย jt
Total biaya operasional
81,99ย jt
37,91ย jt
61,36ย jt
39,63ย jt
Penghasilan operasional
-36,66ย jt
9,72ย jt
54,10ย jt
20,04ย jt
Penghasilan non-operasional lainnya
-2,06ย jt
96,00ย rb
390,00ย rb
1,48ย jt
EBT termasuk item luar biasa
-50,18ย jt
11,22ย jt
141,14ย jt
56,78ย jt
EBT tidak termasuk item luar biasa
-37,81ย jt
10,28ย jt
57,45ย jt
116,80ย jt
Beban pajak penghasilan
-7,73ย jt
6,38ย jt
23,86ย jt
12,00ย jt
Tarif pajak efektif
15,40%
56,81%
16,91%
21,13%
Biaya operasional lainnya
-
-
-
-
Penghasilan bersih
-42,45ย jt
4,85ย jt
117,27ย jt
44,78ย jt
Margin laba bersih
-93,64%
10,18%
101,57%
75,06%
Penghasilan per saham
1,33
1,60
3,09
2,02
Penghasilan bunga dan investasi
1,77ย jt
1,62ย jt
3,87ย jt
6,39ย jt
Beban bunga
-867,00ย rb
-1,15ย jt
-910,00ย rb
-1,78ย jt
Beban bunga bersih
904,00ย rb
468,00ย rb
2,96ย jt
4,61ย jt
Biaya depresiasi dan amortisasi
-
-
-
-
EBITDA
-28,35ย jt
17,82ย jt
63,26ย jt
28,25ย jt
Keuntungan atau kerugian dari penjualan aset
-
-
-
-
Konten AI mungkin berisi kesalahan. Pelajari lebih lanjut
BantuanKirim masukanPrivasiPersyaratanPernyataan penyangkalan

Riset

Tugas saya
Anda belum membuat tugas
Tugas Anda akan muncul di sini. Jadwalkan tugas dan manfaatkan Google Finance saat Anda pergi.
Template
Rangkuman daftar pantauan
Analisis pra-pasar harian untuk daftar pantauan Anda
Penghasilan Mendatang
Laporan penghasilan yang akan dirilis minggu ini
Volatilitas & Volume Abnormal
Peringatan dini terkait volatilitas dan volume hari ini
Konten AI mungkin berisi kesalahan. Pelajari lebih lanjut
BantuanKirim masukanPrivasiPersyaratanPernyataan penyangkalan